References
- Vogt K, Hermann J, Blume U, et al. Comparative activity of the topical quinolone OPC-7251 against bacteria associated with. acne vulgaris. Eur J Clin Microbiol Infect Dis 1992; 11: 943–5
- Bojar R A, Hittel N, Cunliffe W J, et al. Direct analysis of resistance in cutaneous microflora during treatment of acne vulgaris with topical 1% nadifloxacin and 2% erythromycin. Drugs 1995; 49(Suppl 2)164–7
- Gollnick H PM, Vogt K, Hermann J, et al. Topical quinolone OPC-7251: a clinical and microbiological study in acne. Eur J Dermatol 1994; 4: 210–15
- Kurokawa I, Akamatsu H, Nishijima S, et al. Clinical and bacteriological evaluation of OPC-7251 in patients with acne: a double-blind group comparison study versus cream base. J Am Acad Dermatol 1991; 25: 674–81
- Kawabata S, Masada H, Wakebe H, et al. Bacteriological evaluation of OPC-7251, a new pyridone carboxylic acid antimicrobial agent. 2: Therapeutic effect of OPC-7251 cream on experimental infection model in mice. Jpn J Chemother 1989; 37: 1179–83
- Nenoff P, Haustein U F, Keller U. In vitro susceptibility of propionibacteria and staphyloccoi from acne patients to erythromycin. Eur J Acad Dermatol Venerol 1995; 4: 181–2
- Suh B, Lorber B. Quinolones. Antimicrob Ther II 1995; 79: 869–93
- Chu D T, Fernandes P B. Structure-activity relationships of the fluoroquinolones. Antimicrob Agents Chemother 1989; 33: 131–5
- Crumplin G C. Aspects of chemistry in the development of the 4-quinolone antibacterial agents. Rev Infect Dis 1988; 10(Suppl 1)2–9
- Domagala J M, Hanna L D, Heifetz C L, et al. New structure-activity relationships of the quinolone antibacterials using the target enzymes. The development and application of a DNA gyrase assay. J Med Chem 1986; 29: 394–404
- Kawabata S, Ohguro K, Mukai F, et al. Bacteriological evaluation of OPC-7251, a new pyridone carboxylic acid antimicrobial agent. 1. In vitro antibacterial activity. Jpn J Chemother 1989; 37: 1160–78